Table 1 Demographic data of the studied normal participants and diabetic patients
Groups | Control (40 eyes) (M-range) (μm) | NDR (39eyes) ((M-range) (μm) | NPDR (64eyes) ((M-range) (μm) | PDR (33eyes) ((M-range) (μm) |
|---|---|---|---|---|
Age (Y) | 50 ± 0.7 | 59.2 ± 1.1 | 58.3 ± 1.1 | 59.1 ± 1.7 |
OD(%) | (50) 20 | (51.3) 20 | (51.6) 33 | (57.6) 19 |
Sex Male (%) | (60) 24 | (27.2) 11 | (42.2) 27 | (39.4) 13 |
BCVA (LOGMAR) | 0.02 ± 0.01 | 0.09 ± 0.01 | 0.41 ± 0.11 | 0.59 ± 0.07 |
The last FBS (mg/dl) | – | 158.4 ± 5.7 | 189.7 ± 8.3 | 202.1 ± 7.3 |
Duration of diabetes mellitus (Y) | – | 12.3 ± 1.1 | 12.9 ± 0.7 | 16.5 ± 1.1 |
Hypertension number (%) | 2 (5%) | 16 (41%) | 27 (42%) | 17 (51.5%) |
Hyperlipidemia number (%) | 0 (5%) | 15 (38.5%) | 32 (50%) | 16 48.5%) |
DME | 0 (0%) | 0 (0%) | 40 (62.5%) | 19 (57.6%) |